Fundraising FoxOtologic Pharmaceuticals
1 known investors
Find your way into Otologic Pharmaceuticals
Sign up to see every warm intro you have to Otologic Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Otologic Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Otologic Pharmaceutics (OPI) is a pharmaceutical company developing treatments for acute and chronic hearing loss to reduce permanent hearing disorders. Its pipeline includes an oral drug for noise-induced hearing loss and a therapy aimed at regenerating sensory hair cells.
Investors · 1
Frequently asked questions
- What does Otologic Pharmaceuticals do?
- Otologic Pharmaceutics (OPI) is a pharmaceutical company developing treatments for acute and chronic hearing loss to reduce permanent hearing disorders. Its pipeline includes an oral drug for noise-induced hearing loss and a therapy aimed at regenerating sensory hair cells.
- Who are Otologic Pharmaceuticals's investors?
- Otologic Pharmaceuticals's investors include Oklahoma Life Science.